Safety and Effectiveness Study of a Non-Crosslinked HA Alkylamide HYADD(TM) 4 Hydrogel for Osteoarthritis of the Knee
Not Applicable
- Conditions
- Knee Osteoarthritis
- Registration Number
- NCT02187549
- Lead Sponsor
- Fidia Farmaceutici s.p.a.
- Brief Summary
The purpose of this study is to determine whether intra-articular hyaluronic acid provides symptomatic relief of osteoarthritis of the knee.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 332
Inclusion Criteria
- Symptomatic osteoarthritis of the knee.
Exclusion Criteria
- No disorders which could interfere with study required assessments.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Pain Sub-score 26 weeks
- Secondary Outcome Measures
Name Time Method Patient Global Assessment 26 weeks
Trial Locations
- Locations (21)
Achieve Clinical Research
🇺🇸Birmingham, Alabama, United States
Alabama Clinical Therapeutics
🇺🇸Brimingham, Alabama, United States
Elite Clinical Studies
🇺🇸Phoenix, Arizona, United States
Arizona Research Center
🇺🇸Phoenix, Arizona, United States
Med Center
🇺🇸Carmichael, California, United States
Triwest Research Associates
🇺🇸El Cajon, California, United States
Westlake Medical
🇺🇸Thousand Oaks, California, United States
Colorado Orthopedic Consultants
🇺🇸Englewood, Colorado, United States
Chase Medical
🇺🇸Waterbury, Connecticut, United States
Riverside Clinical Research
🇺🇸Edgewater, Florida, United States
Scroll for more (11 remaining)Achieve Clinical Research🇺🇸Birmingham, Alabama, United States